ArticleBreast cancer (Dove Medical Press)2017

SR-B1-targeted nanodelivery of anti-cancer agents: a promising new approach to treat triple-negative breast cancer.

Rebecca Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.